21.02.2017 • Topics

Songwon Enters Distribution Partnership with Biesterfeld Turkey

Songwon has signed an agreement with Biesterfeld Turkey for the distribution of Songwon’s polymer stabilizers.

According to Songwon, the plastics industry in Turkey has shown great potential for growth in the past several years. After Germany, it is now ranked as the second-largest plastics processing country in Europe and since 2003, Biesterfeld Turkey serves more than 2.000 customers in industries such as automotive, appliance, packaging and coatings.

By combining the expertise of the two companies, Songwon sees the agreement as an important step to strengthening both its presence and relationships with customers in Turkey.

“At Songwon, we’re committed to continually enhancing our product availability and level of service for our customers. Partnering with Biesterfeld Turkey further strengthens our distribution network and is a significant step towards our aim of delivering solutions that exceed the expectations of our Turkish customers,” says Paolo Arnaboldi, sales director Europe & India at Songwon.

“We are delighted to be entering an exclusive distributorship with Songwon. We look forward to leveraging our local experience and industry know-how to provide an excellent range of products to Turkish customers, while helping Songwon broaden its market share in Turkey,” adds Ahmet Göktan, managing director at Biesterfeld Turkey.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read